Literature DB >> 3315863

Glycosylation and secretion of human alpha-1-antitrypsin by yeast.

D T Moir1, D R Dumais.   

Abstract

Human alpha-1-antitrypsin (alpha-AT) is a major serum protein with protease inhibitory activity. Three asparagine residues in alpha-AT are glycosylated with the mammalian 'complex' pattern of carbohydrate as the protein is secreted from cells in the liver. To examine the glycosylation and secretion of human alpha-AT by Saccharomyces cerevisiae, the yeast invertase secretion signal codons were substituted for the native secretion signal coding DNA of an alpha-AT cDNA, and the fusion gene was placed on an autonomously replicating yeast--Escherichia coli shuttle vector under control of the yeast triosephosphate isomerase (TPI) promoter. Yeast strains transformed with this plasmid produce human alpha-AT and secrete about one-fifth of it into the culture broth. Approximately 80% of the alpha-AT produced in yeast is not in the culture broth but is inside the cell within the secretory pathway. This internal alpha-AT is heterogeneous, consisting of molecules with core carbohydrate on either two or all three of the asparagine receptors. Human alpha-AT secreted into the culture broth contains, in addition to core carbohydrate, variable numbers of mannose outer chains, typical of secreted yeast proteins such as invertase. All carbohydrate is removed by endoglycosidase H treatment. Examination of alpha-AT secreted from an mnn9 mutant, which blocks addition of variable numbers of outer mannose chains, revealed a homogeneous alpha-AT product which, like alpha-AT isolated from human serum, bears carbohydrate on three asparagine residues per molecule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315863     DOI: 10.1016/0378-1119(87)90138-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

Review 1.  Metabolic engineering of Saccharomyces cerevisiae.

Authors:  S Ostergaard; L Olsson; J Nielsen
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Secretion of functional antibody and Fab fragment from yeast cells.

Authors:  A H Horwitz; C P Chang; M Better; K E Hellstrom; R R Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Yeast mutants deficient in ER-associated degradation of the Z variant of alpha-1-protease inhibitor.

Authors:  A A McCracken; I V Karpichev; J E Ernaga; E D Werner; A G Dillin; W E Courchesne
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

4.  Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ.

Authors:  Kristina B Kruse; Jeffrey L Brodsky; Ardythe A McCracken
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

5.  Strains and Molecular Tools for Recombinant Protein Production in Pichia pastoris.

Authors:  Claudia Rinnofner; Michael Felber; Harald Pichler
Journal:  Methods Mol Biol       Date:  2022

6.  Selective protein degradation in the yeast exocytic pathway.

Authors:  A A McCracken; K B Kruse
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

7.  The yeast Ca(2+)-ATPase homologue, PMR1, is required for normal Golgi function and localizes in a novel Golgi-like distribution.

Authors:  A Antebi; G R Fink
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

8.  Glycan modification of a thermostable recombinant (1-3, 1-4)-beta-glucanase secreted from Saccharomyces cerevisiae is determined by strain and culture conditions.

Authors:  M Meldgaard; J Harthill; B Petersen; O Olsen
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

Review 9.  Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production.

Authors:  Mudassar Ahmad; Melanie Hirz; Harald Pichler; Helmut Schwab
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-18       Impact factor: 4.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.